ClinicalTrials.Veeva

Menu

Collaborative Study of 1,3 Butadiene Biomarkers

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status

Completed

Conditions

Cancer

Study type

Observational

Funder types

NIH

Identifiers

NCT00023140
9401-CP-001

Details and patient eligibility

About

Butadiene is a suspect human carcinogen to which most people are exposed daily. Exposures are difficult to measure by air sampling. This study examines the relationship between air levels and several biomarkers of exposure. Biomarkers are substances analyzed in human tissues or waste products. Adducts are materials formed when a chemical reacts with a biological material. In this study we are looking at biomarkers in the blood: hemoglobin and DNA adducts, and urinary metabolites. If a strong relationship is found then the amounts of biomarkers in a person's blood or urine can tell us how much they have been exposed. The tests are being conducted on petrochemical workers who have a wide range of exposures to butadiene. An international group of investigators is conducting the study.

Sex

All

Ages

19 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Healthy adults without metabolic disorders

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems